Riskpilot← Back to searchSign inGet full accessHOFSETH BIOCARE ASA
ASAActiveOrg 994464663Keiser Wilhelms Gate 24, 6003 ÅlesundManufacture of oils and fats · NACE 1041Est. 200982 employeeswww.hofsethbiocare.com
Revenue 2024
NOK 267M
+22% vs 2023
EBITDA margin
-19.6%
+3% vs 2023
Equity ratio
31.9%
Financial strength
Net profit 2024
NOK -97,9M
-5% vs 2023
| Revenue | NOK 267M | +22% |
| EBITDA | NOK -52,4M | +3% |
| Net profit | NOK -97,9M | -5% |
| Total assets | NOK 377,3M | -5% |
| Equity | NOK 120,4M | +61% |
| Employees | 82 | — |
Legal name
HOFSETH BIOCARE ASA
Org number
994464663
Legal form
Allmennaksjeselskap
NACE code
1041 · Manufacture of oils and fats
Founded
29. august 2009
Share capital
NOK 4 110 810
Employees
82 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Jon olav ødegård
Company purpose
Utvikling, foredling, markedsføring og salg av marine ingredienser som marine oljer, kalslum- og proteinprodukter, samt samarbeid med og deltakelse og eierskap i virksomheter som driver relatert virksomhet.
Address
Keiser Wilhelms Gate 24, 6003 Ålesund
Email
info@hofsethbiocare.no
Website
www.hofsethbiocare.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 68 713 | 88 048 | 119 959 | 218 418 | 267 026 |
| Staff expenses | −36 432 | −37 796 | −47 206 | −51 659 | −60 304 |
| EBITDA | −68 275 | −85 000 | −86 648 | −54 257 | −52 404 |
| Depreciation & amort. | −23 497 | −25 710 | −25 965 | −32 188 | −36 023 |
| EBIT | −91 772 | −110 710 | −112 613 | −86 445 | −88 427 |
| Net financials | −13 505 | −11 531 | −6 754 | −6 551 | −9 471 |
| Profit before tax | −105 277 | −122 241 | −119 367 | −92 996 | −97 898 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −105 277 | −122 241 | −119 367 | −92 996 | −97 898 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 444 647 | 394 064 | 402 642 | 396 716 | 377 251 |
| Equity | 261 621 | 142 765 | 167 823 | 74 612 | 120 422 |
| Long-term debt | 65 791 | 102 776 | 72 492 | 80 248 | 96 922 |
| Short-term debt | 117 235 | 148 523 | 162 327 | 241 856 | 159 907 |
| Total debt | 183 026 | 251 299 | 234 819 | 322 104 | 256 829 |
EBITDA margin
-19.6%
This company
15.8%
Market median
-224% vs market
20202024
Equity ratio
31.9%
This company
38.2%
Market median
+16% vs market
20202024
Return on equity
-81.3%
This company
18.4%
Market median
-542% vs market
20202024
Net profit margin
-36.7%
This company
8.1%
Market median
-553% vs market
20202024
Asset turnover
0.71×
This company
1.12×
Market median
-37% vs market
20202024
Debt / equity
2.13×
This company
0.62×
Market median
-244% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
JO Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (6) | ||
| Board of Directors | 2024 | |
| Board of Directors | 2022 | |
| Board of Directors | 2022 | |
| Board of Directors | 2022 | |
| Chairman | 2024 | |
| Board of Directors | 2024 | |
| Former (4) | ||
| Chairman | 2020 – 2022 | |
| Board of Directors | 2022 – 2024 | |
| Board of Directors | 2020 – 2022 | |
| Chairman | 2022 – 2024 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Six Sis Ag | Company | 22.4% | 22.4% | 2024 |
| Individual | 19.6% | 19.6% | 2022 | |
| Company | 18.39% | 18.39% | 2024 | |
| Company | 16.86% | 16.86% | 2024 | |
Yokorei Co. Ltd | Company | 9.96% | 9.96% | 2024 |
| Individual | 5.68% | 5.68% | 2022 | |
Goldman Sachs International | Company | 5.46% | 5.46% | 2024 |
Ubs Switzerland Ag | Company | 2.95% | 2.95% | 2024 |
| Company | 2.68% | 2.68% | 2024 | |
Citibank, N.A. | Company | 2.48% | 2.48% | 2024 |
Credit Suisse (Switzerland) Ltd. | Company | 2.42% | 2.42% | 2023 |
| Individual | 2.34% | 2.34% | 2022 | |
| Individual | 2.33% | 2.33% | 2022 | |
Goldman Sachs & Co. Llc | Company | 2.25% | 2.25% | 2024 |
| Individual | 2.03% | 2.03% | 2022 | |
| Individual | 1.26% | 1.26% | 2022 | |
| Individual | 1.25% | 1.25% | 2022 | |
Jpmorgan Chase Bank, N.A., London | Company | 1.12% | 1.12% | 2024 |
Bnp Paribas | Company | 1.01% | 1.01% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
HOFSETH BIOCARE ASA 
SALMON COSMETICS ASBoard members of HOFSETH BIOCARE ASA also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jon Olav Ødegård | Chief Executive Officer | 0 companies |
| Ola Holen | Chairman | 0 companies |
| Roger Hofseth | Board of Directors | 0 companies |
| Christoph Johannes Baldegger | Board of Directors | 0 companies |
| Amy Bennett Novogratz | Board of Directors | 0 companies |
| Torill Standal Eliassen | Board of Directors | 0 companies |
| Henriette Godø Heggdal | Board of Directors | 0 companies |
| Crawford Linden Alexander Currie | Board of Directors | 0 companies |
| Linda Christin Hoff | Chairman | 0 companies |
| Kristin Fjellby Grung | Chairman | 0 companies |
| Eva Maria Bech | Board of Directors | 0 companies |